Intravenous immunoglobulin (IVIG)

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Intravenous immunoglobulin (IVIG) and local guidelines before prescribing.

Blood product

Mechanism

Pooled human IgG providing passive immunity and immunomodulation.

Uses

Primary immunodeficiency, ITP, Guillain-Barre syndrome, Kawasaki disease, CIDP, myasthenic crisis.

Dosing

3 more dose entries from the chapters
  • Treatment - IV aciclovir 10 mg/kg every 8 hours (adjusted for kidney function) started immediately on suspicion - don't wait for CT, LP or PCR; usually 14–21 days for confirmed HSV encephalitis; hydrate well; treat seizures; immunotherapy (steroids, IVIG, plasma exchange, rituximab) for autoimmune encephalitis.
    ID: Sepsis, fever and serious bacterial infections
  • Guillain–Barré syndrome | Ascending symmetrical weakness, areflexia , after infection (Campylobacter); back pain, autonomic instability | FVC monitoring (ICU if under 20 mL/kg or falling); IVIG or plasma exchange
    Acute Medicine: Reduced consciousness, seizures, headache and acute confusion
  • High-dose IVIG (immunomodulation, 2 g/kg over 2–5 days) - ITP, Guillain–Barré, CIDP, multifocal motor neuropathy, Kawasaki disease, myasthenic crisis, dermatomyositis, autoimmune encephalitis - NHS England commissioning criteria apply.
    Clinical Immunology: Autoimmunity, autoantibodies and complement

Side effects

Headache, infusion reactions, aseptic meningitis, thrombosis, renal impairment, haemolysis.

Interactions

Live vaccines blunted for months.

Contraindications and cautions

IgA deficiency with anti-IgA antibodies

Monitoring

Renal function, BP, infusion rate

Pregnancy and breastfeeding

Safe

Renal and hepatic impairment

Use slow infusion in renal impairment

Overdose and reversal

Supportive

Special advice

Infuse slowly; hydrate; check IgA deficiency; thrombosis and renal risk in older patients.

More from the textbook: uses, cautions and other points
Where it is discussed in the book